Navigation Links
Instead of Preventing Infections, Silver Coated Needleless IV Connectors May Actually Cause Them, a Nationally-Recognized Expert Tells National Conference on Cancer Nursing Research
Date:2/11/2011

LOS ANGELES, Feb. 11, 2011 /PRNewswire/ -- Nationally-acclaimed researcher and award-winning author Dr. Cynthia C. Chernecky warned in a speech at the 11th National Conference on Cancer Nursing Research that silver treated IV connectors could actually cause potentially deadly infections they were supposed to prevent.

After testing antimicrobial effectiveness of three different needleless IV connector devices with silver coated or silver impregnated fluid pathway components, Dr. Chernecky, PhD, RN, AOCN, FAAN, said that despite FDA clearance of silver coatings, she found they actually grew bugs capable of causing potentially fatal infections.

Presenting to the Oncology Nursing Society and American Cancer Society, the nation's highest-level conference on oncology nursing, Dr. Chernecky's podium address was a wake-up call to leaders in the nursing profession in attendance.  A professor of Physiological and Technological Nursing at Georgia Health Sciences University, Dr. Chernecky was invited to deliver her remarks in one of the conference's prestigious podium presentations.  She is author of 30 books on nursing, including one on "Advance and Critical Care Nursing" that won the distinguished American Journal of Nursing "Book of the Year" Award.

Asked in an interview following her talk how silver-coatings received FDA clearance, Dr. Chernecky said the FDA was presented with evidence from the manufacturers that their silver treated needleless IV connectors were effective in killing bugs.  But when blood comes in contact with the silver coated or impregnated fluid pathway components in practical use, the silver loses its bug-killing capability and an intraluminal or biofilm condition is created that actually nourishes bacteria.  

"The FDA should consider requiring a blood component test protocol when evaluating needleless IV connector products, just as if you were testing a coffee maker you'd want coffee in it to see how good it brews."

According to Dr. Chernecky, all three silver coated/impregnated IV connectors tested grew enough Staphylococcus aureus and Staphylococcus epidermidis bacteria to induce infections. She noted a recent FDA Alert & Notification letter which requires manufacturers of positive displacement IV connectors to prove their devices do not increase catheter-related bloodstream infection (CRBSI) risk. Numerous studies already associate positive displacement connecters with higher rates of CRBSI.

Studies also associate negative displacement needleless IV connectors with higher CRBSI rates, she said, due to higher rates of occlusion. Studies have shown that positive and negative displacement connectors appear unable to control bacterial growth, which may be due in part to the bacteria-nurturing effect of blood reflux within the catheter lumen and the dead space within many of the IV connector fluid pathways that entrap blood and are difficult to effectively flush.  

Dr. Chernecky noted in the last 21 years only one new technology-based needleless IV connector has emerged, an intraluminal protection device (IPD) from RyMed Technologies, a company that has been struggling to penetrate a hospital market dominated by older IV connector systems with either positive or negative displacement.  RyMed's device has zero displacement and therefore is not subject to blood reflux, which may help explain its effectiveness in reducing infections to zero or very near zero at hospitals, home infusion and extended care facilities where it's in use. One of the leading hospital-acquired infections, CRBSI is fatal in up to 25% of cases.

CONTACT: Glen Calder, 561-750-9800 x216

gcalder@transmediagroup.com




'/>"/>
SOURCE Dr. Cynthia C. Chernecky
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
2. China PharmaHub Corp. Begins Trading Under Stock Symbol CPHB Instead of WRLC
3. FDAs Just Approved Monthly Drug Treatment, Vivitrol Could Be Game Changer, Says Countrys Largest Drug Treatment Recovery President, CRCs Jerry Rhodes; Provides Addicts One Decision A Month Instead of 30
4. Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds & Flu
5. Molecular Therapy Succeeds in Preventing Craniofacial Birth Defect in Mice
6. Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Mens Health Week Is June 9-15)
7. F.D.A. Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy
8. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
9. March 2009 Mayo Clinic Health Letter Highlights Knee Repair Surgery, Anxiety Disorder and Preventing Blood Clots
10. Value of Genetic Testing for Preventing Blood Clots Unproven, According to New AHRQ Study
11. HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Research and ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" report ... In-Mold Electronics, Smart Skin, Structural Health Monitoring, ... Structural electronics involves electronic and/or electrical components ... replacing dumb structures such as vehicle bodies or ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/27/2016)... ... 27, 2016 , ... A revolution is underway. Brooklyn-based ... experience for the millions of people who require these medical transport services annually. ... through the use of technology. Now, SmartEMS has put forth an industry-changing app ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
Breaking Medicine News(10 mins):